Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shakeel Modak

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Journal of Pediatric Hematology/Oncology|August 23, 2024
Omalizumab for Treatment of Anti-GD2 Antibody-related UrticariaRachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 4, 2025
Lesion Analysis of <sup>18</sup>F-Metafluorobenzylguanidine PET Imaging in NeuroblastomaNeeta Pandit-Taskar, Ellen Basu, Ali Pirasteh, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk NeuroblastomaAnne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experienceNeil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastomaAnne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Future Oncology (London, England)|March 26, 2015
Desmoplastic small round cell tumor 20 years after its discoveryJaume Mora, Shakeel Modak, Nai-Kong Cheung, et al.
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Journal of Pediatric Hematology/Oncology|August 23, 2024
Omalizumab for Treatment of Anti-GD2 Antibody-related UrticariaRachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 4, 2025
Lesion Analysis of <sup>18</sup>F-Metafluorobenzylguanidine PET Imaging in NeuroblastomaNeeta Pandit-Taskar, Ellen Basu, Ali Pirasteh, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk NeuroblastomaAnne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experienceNeil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastomaAnne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Future Oncology (London, England)|March 26, 2015
Desmoplastic small round cell tumor 20 years after its discoveryJaume Mora, Shakeel Modak, Nai-Kong Cheung, et al.
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Pageof 14